YCBD
cbdMD Inc
NYSE MKT: YCBD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.85
-2.02% today
Updated 2026-04-30
Market cap
$10.18M
P/E ratio
1.62
P/S ratio
0.53x
EPS (TTM)
$0.60
Dividend yield
—
52W range
$0 – $3
Volume
1.8M
cbdMD Inc (YCBD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-12.20%
Operating margin
-5.71%
ROE
-43.40%
ROA
-12.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $12540.00 | $-1.13M | 39.23% | -10,360.37% | -9,017.94% |
| 2016 | $2.03M | $-3.36M | 20.34% | -183.76% | -165.22% |
| 2017 | $4.47M | $-1.74M | 69.71% | -5.35% | -38.85% |
| 2018 | $459091.00 | $-412075.00 | 28.87% | -391.44% | -89.76% |
| 2019 | $23.65M | $-50.43M | 61.37% | -60.72% | -213.21% |
| 2020 | $41.88M | $12.60M | 62.96% | -41.98% | 30.09% |
| 2021 | $44.48M | $-23.39M | 65.13% | -44.10% | -52.60% |
| 2022 | $35.40M | $-70.08M | 57.91% | -48.90% | -197.96% |
| 2023 | $24.16M | $-22.94M | 53.97% | -38.37% | -94.96% |
| 2024 | $19.48M | $-3.70M | 55.67% | -16.37% | -18.99% |
| 2025 | $19.19M | $-2.04M | 56.50% | -11.27% | -10.63% |